New Lung Cancer Considered episode: previewing the upcoming WCLC24

International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:

“In this Lung Cancer Considered episode, host Dr. Narjust Florez previews the upcoming WCLC24 with the meeting’s other 3 co-chairs: Dr. Linda Martin, from the University of Virginia, Dr. Fabio Ynoe de Moraes, from Queen University, and Dr. Sandip Patel, from the University of California San Diego.

Listen Now.”

Source: IASLC/LinkedIn

Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.

Linda Martin, MD, joined the University of Virginia School of Medicine faculty and UVA Cancer Center as an Associate Professor of Surgery. As Chief of Thoracic Surgery, Dr. Martin specializes in thoracic malignancies and has substantial experience treating benign lung and esophageal diseases.

Fabio Ynoe de Moraes, MD, PhD, MBA, is an Associate Professor and clinical investigator in radiation oncology and global oncology at Queen’s University and Kingston Health Sciences Centre in Kingston, Canada. He has worked with institutions like the Hospital Sírio-Libanês, Princess Margaret Cancer Centre, and Memorial Sloan Kettering Cancer Centre.

Sandip Patel, a Professor at UC San Diego Health, specializes in the early development of novel immunotherapies. His work primarily involves conducting early-phase clinical trials in cancer immunotherapy, with a focus on thoracic oncology.